Vaxil Bio Ltd. is a clinical stage biotechnology company which engages in the development of synthetic therapeutic and preventive vaccines. It operates through the Cancer and Tuberculosis therapeutic areas. The Cancer area comprises vaccines for metastatic breast cancer patients in combination with hormonal therapy. The Tuberculosis area involves vaccines to boost immunity in BCG immunized patients and as a theraputic vaccine in TB patients. The company was founded by Lior Carmen and Julian Levy on August 6, 2006 and is headquartered in Nes-Ziona, Israel.